MINAXEN 50MG CAPSULE,HARD

Χώρα: Κύπρος

Γλώσσα: Ελληνικά

Πηγή: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Δραστική ουσία:

MINOCYCLINE HYDROCHLORIDE

Διαθέσιμο από:

DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629

Φαρμακολογική κατηγορία (ATC):

J01AA08

INN (Διεθνής Όνομα):

MINOCYCLINE

Δοσολογία:

50MG

Φαρμακοτεχνική μορφή:

CAPSULE,HARD

Σύνθεση:

MINOCYCLINE HYDROCHLORIDE (0013614987) 53,98MG

Οδός χορήγησης:

ORAL USE

Τρόπος διάθεσης:

Εθνική Διαδικασία

Θεραπευτική περιοχή:

MINOCYCLINE

Περίληψη προϊόντος:

Νομικό καθεστώς: Με Ιατρική Συνταγή; PACK WITH 30 CAPS IN BLISTER(S) (950020501) 30 CAPSULE - Εγκεκριμένο - Με Ιατρική Συνταγή

Φύλλο οδηγιών χρήσης

COMPARATIVE TABLE ENGLISH VS GREEK PIL
PACKAGE LEAFLET: INFORMATION FOR THE USER
MINAXEN 50 MG CAPSULES
Minocycline (as Minocycline hydrochloride)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes
any possible side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Minaxen is and what it is used for
2.
What you need to know before you take Minaxen
3.
How to take Minaxen
4.
Possible side effects
5.
How to store Minaxen
6.
Contents of the pack and other information
1.
WHAT MINAXEN IS AND WHAT IT IS USED FOR
Minaxen is indicated for the treatment of:
A – the following infections caused by the mentioned microorganisms
that are
ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ
ΤΟ ΧΡΉΣΤΗ
ΜINAXEN 50 MG ΚΑΨΆΚΙΑ
Μινοκυκλίνη (ως υδροχλωρική
Μινοκυκλίνη)
ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ
ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΙΝ
ΑΡΧΊΣΕΤΕ
ΝΑ
ΠΑΊΡΝΕΤΕ
ΑΥΤΌ
ΤΟ
ΦΆΡΜΑΚΟ,
ΔΙΌΤΙ
ΠΕΡΙΛΑΜΒΆΝΕΙ
ΣΗΜΑΝΤΙΚΈΣ ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ.

Φυλάξτε αυτό το φύλλο οδηγιών χρήσης.
Ίσως χρειαστεί να το
διαβάσετε ξανά.

Εάν έχετε περαιτέρω απορίες, ρωτήστε
το γιατρό ή το φαρμακοποιό
σας.

Η συνταγή για αυτό το φάρμακο
χορηγήθηκε αποκλειστικά για σας.
Δεν πρέπει να δώσετε το φάρμακο σε
άλλους. Μπορεί να

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Minaxen 50 mg Capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains 50 mg of minocycline as minocycline
hydrochloride.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Capsules
Light orange, hard gelatin capsule size 3, containing light yellow
powder.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Minaxen is indicated for the treatment of:
Α- the following infections that are caused by the mentioned
microorganisms that are
sensitive to minocycline:
Rickettsioses including ehrlichiosis, Q fever, of spotted fever,
trench fever and typhus.
Respiratory tract infections caused by Mycoplasma pneumoniae.
Venereal lymphogranuloma caused by Chlamydia trachomatis.
Psittacosis caused by Chlamydia psittaci.
Trachoma and conjunctivitis caused by Chlamydia trachomatis.
Non-gonococcal urethritis, trachilitis, or proctitis caused by
Chlamydia trachomatis or
ureaplasma urealyticum.
Infections of the upper and lower respiratory caused by Chlamydophila
pneumoniae.
Relapsing fever caused by Borrelia recurentis.
Early stages of Lyme disease caused by Borrelia burgdorferi.
Chancroid caused by Haemophilus ducreyi.
Plaque caused by Yersinia pestis, in combination with streptomycin.
Tularemia caused by Francisella tularensis.
Cholera caused by Vibrio cholerae.
Infections caused by campylobacter fetus.
Brucellosis in combination with streptomycin or rifampicin.
Bartonellosis caused by Bartonella bacilliformis.
Lymphogranuloma inguinale caused by Callymmatobacterium granulomatis.
Inflammatory diseases of the small pelvis (pyelitis) in women.
B- Infections caused by the following gram-negative bacteria when
culture testing indicates
sensitivity to minocycline:
Escherichia coli.
Enterobacter aerogenes.
Shigella species.
Acinetobacter species.
Respiratory tract infections caused by Haemophilus influenza.
Respiratory tract and urinary tract infections caused by Klebsiella
species.
1
C- Infections caused by gram- positive bacte